Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Incidence, risk factors, and outcome

Clinical Microbiology and Infection

Volumn 16, Issue 7, 2010, Pages 870-877

  Guinea, J ^a,b   Torres Narbona, M ^a   Gijon P ^a   Munoz P ^a,b   Pozo, F ^b,c   Pelaez T ^a,b   de Miguel, J ^a   Bouza, E ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Aspergillosis; Aspergillus; Chronic obstructive pulmonary disease; Logistic model; Mortality; Risk factors

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CEFTRIAXONE; CORTICOSTEROID; GALACTOMANNAN; ITRACONAZOLE; PIPERACILLIN PLUS TAZOBACTAM; VORICONAZOLE;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNGUS CULTURE; FUNGUS ISOLATION; HEART FAILURE; HUMAN; INFECTION RATE; INFECTION RISK; INTENSIVE CARE; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

ASPERGILLUS;

EID: 77954647333     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03015.x     Document Type: Article

References (38)

1. Patterson TF, Kirkpatrick WR, White M. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000, 79:250-260.
2. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005, 18:44-69.
3. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002, 100:4358-4366.
4. Marr KA, Patterson T, Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002, 16:875-894. vi
5. Perea S, Patterson TF. Invasive Aspergillus infections in hematologic malignancy patients. Semin Respir Infect 2002, 17:99-105.
6. Cornillet A, Camus C, Nimubona S. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006, 43:577-584.
7. Bouza E, Guinea J, Peláez T, Pérez-Molina J, Alcalá L, Muñoz P. Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. J Clin Microbiol 2005, 43:2075-2079.
8. Ader F, Nseir S, Le Berre R. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 2005, 11:427-429.
9. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007, 30:782-800.
10. Samarakoon P, Soubani AO. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis 2008, 5:19-27.
11. Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007, 45:205-216.
12. Bulpa PA, Dive AM, Garrino MG. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med 2001, 27:59-67.
13. Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998, 26:1473-1475.
14. Agustí C, Rano A, Aldabo I, Torres A. Fungal pneumonia, chronic respiratory diseases and glucocorticoids. Med Mycol 2006, 44(suppl):207-211.
15. Barouky R, Badet M, Denis MS, Soubirou JL, Philit F, Guerin C. Inhaled corticosteroids in chronic obstructive pulmonary disease and disseminated aspergillosis. Eur J Intern Med 2003, 14:380-382.
16. Garcés Jarque JM, Terradas Robledo R, Álvarez-Lerma F, Grau Cerrato S, Salvado Costa M, Torres-Rodríguez JM. Lung aspergillosis. Role of the corticoids as associated risk factor in the patient with chronic bronchitis. Rev Clin Esp 2003, 203:472-474.
17. Ader F, Nseir S, Tillie-Leblond I, Guery B. Acute invasive pulmonary aspergillosis in chronic lung disease. a review. Rev Mal Respir 2006, 23(3 Suppl):6511-6520.
18. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996, 100:171-178.
19. Perfect JR, Cox GM, Lee JY. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001, 33:1824-1833.
20. Khasawneh F, Mohamad T, Moughrabieh MK, Lai Z, Ager J, Soubani AO. Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. J Crit Care 2006, 21:322-327.
21. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005, 9:R191-R199.
22. Murray P, Baron E, Pfaller M, Tenover F, Yolken R. Aspergillus, fusarium and other opportunistic moniliaceous fungi. Manual of Clinical Microbiology 1999, 1212-1241. In, American Society for Microbiology, pp
23. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
24. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:909-917.
25. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am 2003, 17:113-134. viii
26. Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003, 22:258-266.
27. Singh N, Pruett TL, Houston S. Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl 2006, 12:1205-1209.
28. Muñoz P, Alcalá L, Sánchez Conde M. The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis. Transplantation 2003, 75:326-329.
29. Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent JL. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003, 15:71-75.
30. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis 1998, 27:1138-1147.
31. Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect 2006, 12:1060-1076.
32. Vandewoude KH, Blot SI, Depuydt P. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 2006, 10:R31.
33. Vandewoude K, Blot S, Benoit D, Depuydt P, Vogelaers D, Colardyn F. Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. Acta Clin Belg 2004, 59:251-257.
34. Beaulieu-Genest L, Chretien D, Maltais F, Pelletier K, Parent JG, Lacasse Y. Self-administered prescriptions of oral steroids and antibiotics in chronic obstructive pulmonary disease: are we doing more harm than good? Chron Respir Dis 2007, 4:143-147.
35. De Pauw B, Walsh TJ, Donnelly JP. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
36. Guinea J, Jensen J, Peláez T. Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp. Med Mycol 2008, 14:1-5.
37. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004, 170:621-625.
38. Caillot D, Casasnovas O, Bernard A. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997, 15:139-147.